Karen Leung Foundation is committed to advancing evidence-based innovations that improve women’s health outcomes and expand access to life-saving screening. Emerging research from Hong Kong demonstrates that self-collected samples—including vaginal, urine, and menstrual blood—show strong concordance with clinician-collected methods for detecting high-risk HPV, the leading cause of cervical cancer.

Notably, self-collected vaginal samples demonstrate comparable sensitivity and specificity in identifying high-grade cervical lesions, highlighting a promising pathway to more accessible, acceptable, and scalable screening approaches. These advancements have the potential to reduce barriers to early detection, particularly for women who face cultural, logistical, or systemic challenges in accessing traditional screening services.

By supporting research and awareness in HPV detection and prevention, Karen Leung Foundation continues to champion innovative, inclusive solutions that empower women to take charge of their health and accelerate progress toward the elimination of cervical cancer.

To read more about visit the National Library of Medicine or download below.